Translating the biology of aging into new therapeutics for alzheimers disease: senolytics
Senolytic FOXO4-DRI can inhibit FOXO4 binding by disrupting the p53-FOXO4 interaction and selectively cause apoptosis via p53 nuclear exclusion in senescent cells and aging mouse models, which may be a promising approach for preventing senescence 11
Which method of delivery you receive will depend on what condition you are seeking treatment for
But, he added, we did not have the corresponding benefit on cognition we had hoped for. Just a week later, a smaller, Phase 2 trial of liraglutide, another GLP-1 agonist, reported no change in glucose metabolism in the brain and mixed results on two scores of cognition
Ending slightly early is better than running out mid-protocol next time
Deze gecombineerde aanpak maakt BPC-157 extra interessant binnen bredere onderzoeksprotocollen